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by the C/EBPb diﬁciency in the chondrocytes. p57 was co-localized with
C/EBPb in late proliferative and pre-hypertrophic chondrocytes of the
growth plate, which was dramatically decreased by the C/EBPb deﬁciency.
The promoter activity of p57 was enhanced by C/EBPb transfection.
Deletion, mutagenesis, and tandem-repeat analyses of the luciferase
assay identiﬁed the core responsive element to be between the −150
and −130 bp region containing a putative C/EBP-binding motif. EMSA
revealed the binding of C/EBPb-overexpressed nuclear extracts with the
oligonucleotide including this region, whose speciﬁcity was veriﬁed by the
C/EBPb antibody supershift. The knockdown of p57 by the siRNA inhib-
ited the C/EBPb-induced hypertrophic differentiation in cultured chondro-
cytes.
Conclusions: C/EBPb directly transactivates p57 at a speciﬁc C/EBP
motif to promote transition from proliferation to hypertrophic differentiation
of chondrocytes during skeletal growth, indicating the essential role of the
C/EBPb/p57 signal during endochondral ossiﬁcation.
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Purpose: Mitochondria are involved in many cellular processes, and
mitochondrial dysfunctions have been associated with apoptosis, aging
and a number of pathological conditions, including osteoarthritis (OA).
Therefore, mitochondrial proteins are an attractive target to study the
metabolism of chondrocyte and its role in cartilage degradation. We
aimed in this work to analyze the mitochondrial protein changes that
are characteristic of OA chondrocytes, and identify a new OA-related
mitochondrial protein proﬁle.
Methods: Chondrocytes were obtained from OA patients undergoing
joint replacement, and cartilages from autopsies without history of joint
disease. Mitochondria were isolated by differential centrifugation pro-
cesses. Protein proﬁling was carried out using the differential in-gel
electrophoresis technology (DIGE). Brieﬂy, mitochondrial proteins from
control and OA samples were labelled with different ﬂuorescent dyes and
co-resolved by 2D gel electrophoresis using a pool of all samples as
internal standard. Biological variation analysis, statistics and hierarchical
clustering were performed using DeCyder software. OA-related proteins
were identiﬁed by MALDI-TOF/TOF mass spectrometry. Validation of
the results was carried out by real-time PCR, Western blotting and
immunoﬂuorescence analyses. Pathway analysis was performed using
PathwayStudio software.
Results: We examined more than 1500 protein spots that were present
in the six different DIGE gels. Both qualitative and quantitative changes
in protein abundance patterns were studied, considering changes within
95% conﬁdence interval and standardized average ratios exceeding 1.3
in at least four of the six analyzed gels. 28 protein spots were found
to be increased in OA cells, including the TNFa-receptor-associated
protein and two subunits of the mitochondrial respiratory chain com-
plex I. On the other hand, 45 protein spots were decreased in OA
chondrocytes, including two mitoﬁlin and two mitochondrial superoxide
dismutase (MnSOD, ratio −1.6, p =0.0024) forms. Unsupervised Princi-
pal Component Analysis and hierarchical clustering (HCA) of these 73
differentially present proteins – 22 of them which were previously deﬁned
as mitochondrial (Figure 1) – allowed the deﬁnition of two different protein
proﬁles corresponding to OA and control samples. Network analysis
was accomplished to evaluate the biological functions affected by this
chondrocyte mitochondrial dysregulation in OA. Validation of the results
was performed for MnSOD by western blot and real time PCR on OA
and normal chondrocyte protein extracts. We also found MnSOD protein
levels signiﬁcantly decreased in osteoarthritic cartilage superﬁcial layer
when compared to control.
Conclusions: This study describes the differences between the mito-
chondrial protein proﬁles of normal and OA chondrocytes, evidencing the
mitochondrial dysregulation that takes place during cartilage degradation
in osteoarthritis. Reduction of MnSOD in OA chondrocytes suggests a
decreased antioxidant activity of cartilage cells that might contribute to
tissue degradation.
Figure 1. Mitochondrial proteins altered in OA. A: Proteome map indi-
cating those mitochondrial proteins that exhibit differences in abundance
when compared to control. B: Unsupervised hierarchical clustering of
the 22 identiﬁed mitochondrial proteins, indicating the variations in abun-
dance.
A28 THE PROGERIA-ASSOCIATED PROTEIN LAMIN A IS
UPREGULATED IN OSTEOARTHRITIS: EVIDENCE FOR
PREMATURE CHONDROCYTE SENESCENCE
A. Ben-Artzi, M. Attur, M. Dave, H. Al-Mussawir, G. Palmer,
S.B. Abramson. NYU Hospital for Joint Diseases, New York, NY, USA
Purpose: Evidence suggests that cell aging or senescence is impor-
tant in the pathogenesis of osteoarthritis (OA). Indeed, by analogy to
neurodegenerative disorders, OA has been termed by Aigner as the
“M. Alzheimer” of articular cartilage. In certain forms of progeria, a defect
in lamin A processing leads to accelerated aging of mesenchymal tissues,
and development of OA at a very young age. In the current study, we
report that OA chondrocytes accumulate lamin A, leading to activation of
caspase 3 and mitochondrial dysfunction.
Methods: Human OA cartilage samples and chondrocytes were isolated
from patients undergoing knee replacement surgery as approved by IRB.
Standard Western Blot, ﬂuorescent microscopy, and Q-PCR techniques
were used. Anti-human lamin A antibody was purchased from Abcam
Inc. TUNEL staining (Roche), ATP Bioluminescence assays (Sigma), and
activated caspase 3 assays (R&D) were performed per manufacturer’s
recommendations.
Results: Lamin A expression was markedly increased (immuno blot) in
chondrocytes derived from OA cartilage samples (n = 6) when compared
with age matched healthy controls (n = 4). Q-PCR analysis demonstrated
a signiﬁcant increase in the Lamin A: Lamin B mRNA ratio in the OA
samples (2.9±0.4 in healthy controls vs. 7.2±1.7 in OA subjects). Since
Il-1b and PGE2 are catabolic mediators, which have been shown to
promote apoptosis in OA chondrocytes, we explored their effects on lamin
A expression. Il-1b caused little to no change in lamin A expression. In
contrast the exposure of chondrocytes to PGE2 (10 uM) caused a marked
increased lamin A accumulation (Western blot) in a rimmed pattern
around the nucleus (confocal microscopy), as well as an increase in
lamin A:lamin B mRNA ration (Q-PCR). This pattern of increased protein
expression and lamin A:lamin B mRNA mimicked that observed in OA
cartilage, suggesting that PGE2 augments lamin A expression via post-
translational mechanisms. These effects by exogenous PGE2 on lamin A
expression were blocked by antagonists of the EP2 receptor, but not
